Mulas F, X. Wang, S. Song, G. Nishanth, W. Yi, A. Brunn, P.K. Larsen, B. Isermann, U. Kalinke, A. Barragan, M. Naumann, M. Deckert, D. Schlüter D (2020) The deubiquitinase OTUB1 augments NF-kB dependent [...] results from 2006 to 2023. Front Mol Biosci. 11:1395410. doi: 10.3389/fmolb.2024.1395410. Harit K, R. Bhattacharjee, K. Matuschewski, J. Becker, U. Kalinke, D. Schlüter*, G. Nishanth* (2023) The deubiquitinating [...] infection. Trends Microbiol. 30(1): 22-33. doi: 10.1016/j.tim.2021.04.002. Koschel J, G. Nishanth, S. Just, K. Harit, A. Kröger, M. Deckert, M. Naumann, D. Schlüter (2021) OTUB1 prevents lethal hepatocyte necroptosis

responses. Immunity . 2021 Feb 9;54(2):340-354.e6. Gaborit BJ, Bergmann J-F, Mussini C, Arribas JR, Behrens G, Walmsley S, Pozniak A, Raffi F. Plea for multitargeted interventions for severe COVID-19. Lancet Infect [...] 1016/S1473-3099(20)30312-1 Safreed-Harmon K, Anderson J, Azzopardi-Muscat N, Behrens GMN, d'Arminio Monforte A, Davidovich U, Del Amo J, Kall M, Noori T, Porter K, Lazarus JV. Reorienting health systems [...] 22(8):839-50. Stankov MV, El Khatib M, Kumar Thakur B, Heitmann K, Panayotova-Dimitrova D, Schoening J, Bourquin JP, Schweitzer N, Leverkus M, Welte K, Reinhardt D, Li Z, Orkin SH, Behrens GM, Klusmann JH. Histone

PLoS One 2015; 10: e0136914. Hernandez PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hölscher C, Dumoutier L, Renauld JC, Suerbaum S, Staeheli P, Diefenbach A. Interferon-lambda [...] against Staphylococcus aureus infection. Pathogens 2015; 4: 722-738. Janik K, Bode J, Dutow P, Laudeley R, Geffers R, Sommer K, Glage S, Klos A. Temperature and host cell-dependent changes in virulence [...] secretory antibodies to gut microbiota. Nat Immunol 2015; 16: 880-888. Lutze B, Chaberny IF, Graf K, Krauth C, Lange K, Schwadtke L, Stahmeyer J, von Lengerke T. Intensive care physicians' and nurses' perception

https://doi.org/10.1186/s12889-024-18705-5 2020 Safieddine B, Sperlich S, Beller J, Lange K, Epping J, Tetzlaff J, Tetzlaff F, Geyer S . Socioeconomic inequalities in type 2 diabetes in employed individuals, [...] ins B, Claas F, Dipchand A I, Eifert S, Eiz-Vesper B, Epping J, Falk C S, Foster B, Geyer S , Gjertson D, Greer M, Haubitz M, Lau A, Maecker-Kolhoff B, Memaran N, Messner H A, Ostendorf K, Samuel U, Schmidt [...] den Gesundheitswissenschaften. In: Hurrelmann K, Razum O, editors. Handbuch Gesundheitswissenschaften. 6th ed. Weinheim: Beltz; 2016. p. 343-74. 2015 Trachte F, Sperlich S, Geyer S . Kompression oder Expansion

Chung B, Cope H, Costales M, Cuvertino S, Dinkel P, Erripi K, Fry AE, Garavelli L, Guan K, Hoffjan S, Janzarik WG, Koenig M, Kreimer I, Kuenzel K, Mancini G, Marin-Reina P, Meinhardt A, Niehaus I, Pilz D [...] D, Ricca I, Simarro FS, Schrock E, Marquardt A, Taft MH, Tezcan K, Thunström S, Verhagen J, Verloes A, Wollnik B, Krawitz P, Hsieh T-C, Zeef L, Seifert M, Heide M, Lawrence CB, Roberts N, Manstein DJ, [...] Preprint Medarxiv , 2024. Hecquet T, Arbogast N, Suhner D, Goetz A, Amann G, Yürekli S, Marangoni F, Greve JN , Di Donato N, Reymann AC Classification of human actin pathological variants using C. elegans

S., Cicconetti, C., Anselmi, F., Kankowski, S., Lang, L., Basic, M., Bleich, A., Bolsega, S., Steglich, M., Oliviero, S., Raimondo, S., Bizzotto, D., Haastert-Talini, K.* and Ronchi, G.* Gut Microbes [...] Meyer, C.*, Stenberg, L.*, Gonzalez-Perez, F.*, Wrobel, S., Ronchi, G., Udina, E., Suganuma, S., Geuna, S., Navarro, X., Dahlin, L.B., Grothe, C.*, Haastert-Talini, K.* Biomaterials. 2016; 76:33-51. doi: 10 [...] Schwann Cells: A Two-Centre Study. Huang, Z.*, Powell, R*, Kankowski, S., Philips, J.B., Haastert-Talini, K. Int. J. Mol. Sci. 2023, 24(6), 5366; doi: 10.3390/ijms24065366 In Vivo and In Vitro Evaluation of a

der Peritonealfibrose zu erreichen. Ausgewählte Publikationen Kiyan Y, Tkachuk S, Kurselis K, Shushakova N, Stahl K, Dawodu D, Kiyan R, Chichkov B, Haller H. Heparanase-2 protects from LPS-mediated endothelial [...] eCollection 2020. Wang L, Balzer MS, Rong S, Menne J, von Vietinghoff S, Dong L, Gueler F, Jang MS,Xu G, Timrott K, Tkachuk S, Hiss M, Haller H, Shushakova N. Protein kinase C α inhibition prevents peritoneal [...] endothelial injury by inhibiting TLR4 signalling. Sci Rep. 2019 Sep 19;9(1):13591. Njau F, Shushakova N, Schenk H, Wulfmeyer VC, Bollin R, Menne J, Haller H.Calcium dobesilate reduces VEGF signaling by interfering

doi: 10.21873/invivo.12560. PMID: 34410965; PMCID: PMC8408701. Relja B, Yang B, Bundkirchen K, Xu B, Köhler K, Neunaber C. Different experimental multiple trauma models induce comparable inflammation and [...] 3109/1354750X.2016.1171908. Epub 2016 Apr 27. PMID: 27120970. Relja B, Horstmann JP, Kontradowitz K, Jurida K, Schaible A, Neunaber C, Oppermann E, Marzi I. Nlrp1 inflammasome is downregulated in trauma patients [...] Sie folgend eine Übersicht der Publikationen der AG Polytrauma ab dem Jahr 2015: Long Y, Bundkirchen K, Gräff P, Krettek C, Noack S, Neunaber C. Cytological Effects of Serum Isolated from Polytraumatized

. Kriedemann N, Manstein F, Hernandez-Bautista CA, Ullmann K, Triebert W, Franke A, Mertens M, Stein ICAP, Leffler A, Witte M, Askurava T, Fricke V, Gruh I, Piep B, Kowalski K, Kraft T, Zweigerdt R., Stem [...] chain expression in human stem cell-derived cardiomyocytes at single-cell level. Osten F, Bodenschatz AK, Ivaskevica K, Kröhn S, Piep B, Holler T, Teske J, Montag J, Iorga B, Weber N, Zweigerdt R, Kraft T [...] aggregates in stirred spinner flasks. Kriedemann N, Triebert W, Teske J, Mertens M, Franke A, Ullmann K, Manstein F, Drakhlis L, Haase A, Halloin C, Martin U, Zweigerdt R., Nat Protoc. 2024 Jul;19(7):1911-1939

Hillemanns b, G. Scambia c, J. Jarkovsky d, J. Persson e, F. Raspagliesi f, Z. Novak g, A. Jaeger h, M.E. Capilna i, V. Weinberger j, J. Klat k, R.L. Schmidt l, A. Lopez m, G. Scibilia n, R. Pareja o, A [...] chen - Authors: C. von Kaisenberg, R. Chaoui, M. Häusler, K. O. Kagan, P. Kozlowski, E.Merz, A. Rempen, H. Steiner, S. Tercanli, J. Wisser, K. S. Heling Gynäkologische Dysplasie-Einheit A Therapeutic [...] Diagnostik (= DEGUM-Stufe II) im Zeitraum von 18 + 0 bis 21 + 6 Schwangerschaftswochen - Autoren: E. Merz, K.-H. Eichhorn, C. von Kaisenberg, T. Schramm - Arbeitsgruppe der DEGUM-Stufe III Qualitätsanforderungen